Maravai LifeSciences Announces June 2021 Investor Conference Schedule
May 26, 2021 16:10 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
May 10, 2021 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021
May 05, 2021 16:10 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021
April 13, 2021 16:15 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators,...
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 12, 2021 16:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
April 07, 2021 20:20 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
April 05, 2021 17:30 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...
Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
April 05, 2021 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai or the Company) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and...
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
March 15, 2021 08:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, has expanded its...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
March 02, 2021 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...